- Visibility 75 Views
- Downloads 49 Downloads
- Permissions
- DOI 10.18231/j.ijirm.2019.024
-
CrossMark
- Citation
To study different etiological and prognostic factors in patients suffering from ARDS/ALI
- Author Details:
-
Praveen Subhash Chabukswar *
-
Jaya Bhaskar Baviskar
Background: Acute inflammatory reaction in the lung which causes injury to the endothelial cells and alveolar epithelium are main pathological changes that may occur in ARDS. This leads to pulmonary edema which eventually causes respiratory failure in these patients. Multiple organ dysfunction syndrome (MODS) is common consequence in these patients. Mortality rate corresponds to the severity of underlying disease and it ranges from 10% to 90%.
Methodology: All patients were screened for the diagnostic criteria of ARDS as per the 1994 American European Consensus Conference on ARDS/ALI. Different scores suggesting outcome were calculated on admission to intensive care unit. Objectives of study were [1] To identify the different risk factors responsible for ARDS/ALI, [2] To study the lung functions in ARDS/ALI survivors, [3] To analyze the effect of treatment strategies on lung functions in survivor, [4] To study different scoring systems.
Results: In our study we had a total of 65 patient, out of which 35 survived. The risk factors for developing ALI/ARDS were pneumonia, tropical diseases, postoperative sepsis, poly trauma, tuberculosis, malignancy, poisoning and neurological disorder.
Conclusions: Pneumonia and tropical diseases are the common risk factor for the ARDS/ALI. The presence of co-morbid conditions also affects the outcome of ALI/ARDS patients. MODS of >4, LIs >2 and APACHE II >2 had associated with higher mortality.
Keywords: ARDS; ALI; Pneumonia.
References
- Atabai K, Matlhay MA. Acute lung injury and acute respiratory distress syndrome: definitions and epidemiology. Thorax 2002:57:452-8.
- Hyers TM, Gee M, Andreadis NA. Cellular interactions in multiple organ injury syndrome. Am Rev Respire Dis 1987;135(4):952-3.
- Renaldo Jest Chrisman JW. Mechanisms and mediators of adult respiratory distress syndrome. Cline Chest Med 1990;11:621. Praveen Subhash Chabukswar et al. To study different etiological and prognostic factors in patients suffering…. IP Indian Journal of Immunology and Respiratory Medicine, April-June, 2019;4(2):104-108 108
- Bone CT Balk RA, Cierra Fats. ACCP SCCM consensus conference: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in Sepsis. Chest 1991;101:1644.
- Montgomery BR, Stager MA, Carrick CJ, Hudson LD: Causes of mortality in patients with the adult Respiratory distress syndrome. Am Rev Respire Dis 1985:132:484.
- Neff Thomas A, Stocker Recto, Frey Hans-Rudolf, Stein Sonja, Russia Erich W. Long-term Assessment of Lung Function in Survivors of Severe ARDS. Chest 2003:123:845-
- Arabia K, Mathai MA. Acute lung injury and acute respiratory distress syndrome: definitions and epidemiology. Thorax 2002:57:452-8.
- Artigas A, Carlit J, Legal JR, Chas tang CL, Blanch L, Fernandez K, et al. Clinical presentation, prognostic factors, and outcome of ARDS in the European Collaborative Study (1985-1987): preliminary report. In W. Ziploc and F. Lemaitre, editors. Adult Respiratory Distress Syndrome. Marcel Dekker 1991;50:37-63.
- Kraft P, Fredric P, Pernerstorfer T. The acute respiratory distress syndrome: definitions, severity and clinical outcome: an analysis of 101 clinical investigations. Intensive Care Med 1996;22:519-29.
- Jordin F, Fellahin JL, Beached A. Improved prognosis of acute respiratory distress syndrome 15 years on. Intensive Care Med 1999;25:936-41.
- Eisner MD. Thompson T, Hudson LD. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and acute respiratory distress syndrome. Am J Respire Crist Care Med 2001;164:231-6.
- Ray P. Protection of epithelial cells by keratinocyte growth factor signaling. Proc Am Throat Soc 2005;2(3):221-5.
- Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, et al. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Cline Invest 2004;114(9):1308-16.
- Cornet AD1, van Nieuw Amerongen GP, Beishuizen A, Schultz MJ, Girbes AR, Groeneveld AJ. Activated protein C in the treatment of acute lung injury and acute respiratory distress syndrome. Expert Opin Drug Discov 2009;4(3):219-27.
- Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. International Surviving Sepsis Campaign Guidelines Committee. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock 2008. Crit Care Med 2008;36:296–327.
- Sharma SK, Mohan A. Acute respiratory distress syndrome. In: Grover A, Aggarwal V, Gera P, Gupta R, editors. Manual of medical emergencies. 3rd edn. Delhi: Pushpanjali Medical Publishers 2007;396–402.
- Sharma SK, Mohan A. Acute respiratory distress syndrome. In: Manoria PC, editor. Postgraduate medicine. Mumbai: Assoc Physicians India. 2005;19:135–51.
- Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007;369:1553–64.
- Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818–24.
- Vigg A, Mantri S, Vigg Avanti, Vigg A: Clinical profile of ARDS. JAPI 2003;51:855-8.
- Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU; comorbid conditions, age, etiology, and hospital outcome. Am J Respire Crist Care Med 1998;157:1159-64.
- Fallow L, Vera SR, Fernandez AK, Silva DR, Rossetti MC, Acute lung injury and adult respiratory distress syndrome at the intensive care unit of a general university hospital in Brazil. An epidemiological study using American-European Consensus Criteria. Intensive Care Med 2002;28(11)1644-8.
- Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983–1993. JAMA 1995;273(4):306–9.
- Sloane PJ, Gee MH, Gottlieb JE, et al. A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. Am Rag Respire Dis 1992;146:419-
- Suchyta, MR., Calmer TP, Elliott CG, Orem JF Jr, Weaver L. The adult respiratory distress syndrome: a report of survival and modifying factors. Chest 1992;101:1074-9.
- Doyle RL, Szaflarski N, Morin GW, -Evener- Cornish JP MA. Identification of patients with acute lung injury: predictors or mortality. Am J Respire Crist Care Med 1995;152:1818-24.
- Ice JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF et al. Ineffectiveness of high-dose methylprednisolone in preventing parenchyma lung injury and improving mortality in patients with septic shock. Am Rev Respired Dis 1988;136:62-8.
- Sprung CI, Carli’s PV, Marcia EH. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engle J Med 1984;311:1137-43.
How to Cite This Article
Vancouver
Chabukswar PS, Baviskar JB. To study different etiological and prognostic factors in patients suffering from ARDS/ALI [Internet]. IP Indian J Immunol Respir Med. 2019 [cited 2025 Oct 16];4(2):104-108. Available from: https://doi.org/10.18231/j.ijirm.2019.024
APA
Chabukswar, P. S., Baviskar, J. B. (2019). To study different etiological and prognostic factors in patients suffering from ARDS/ALI. IP Indian J Immunol Respir Med, 4(2), 104-108. https://doi.org/10.18231/j.ijirm.2019.024
MLA
Chabukswar, Praveen Subhash, Baviskar, Jaya Bhaskar. "To study different etiological and prognostic factors in patients suffering from ARDS/ALI." IP Indian J Immunol Respir Med, vol. 4, no. 2, 2019, pp. 104-108. https://doi.org/10.18231/j.ijirm.2019.024
Chicago
Chabukswar, P. S., Baviskar, J. B.. "To study different etiological and prognostic factors in patients suffering from ARDS/ALI." IP Indian J Immunol Respir Med 4, no. 2 (2019): 104-108. https://doi.org/10.18231/j.ijirm.2019.024